SanBio Company Limited

TSE:4592.T

1080 (JPY) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) JPY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q4
Revenue 00000000000000000022.882-3.424238.373189.395172.72153.297257.145158.452119.215121.37126.054123.87191.53673.67158.738625.59875.16688.231126.555284.698109.118
Cost of Revenue 2.5012.4422.3923.4834.0944.5355.3086.4836.5056.31924.94233.41841.15532.95200000000000000001700000000
Gross Profit -2.501-2.442-2.392-3.483-4.094-4.535-5.308-6.483-6.505-6.319-24.942-33.418-41.155-32.952000022.882-3.424238.373189.395172.72153.297257.145158.452119.215121.37126.054123.87174.53673.67158.738625.59875.16688.231126.555284.698109.118
Gross Profit Ratio 0000000000000000001111111111110.91111111111
Reseach & Development Expenses 637.317387.101402.576334.911,063.331,048.7741,137.0311,360.3182,250.4211,370.3551,409.3021,294.8191,124.7651,126.4991,097.1741,175.8941.45857.2171,465.451848.661917.971,095.6471,223.848828.048696.668972.4781,156.448998.6421,071.866929.145641.938471.452577.992366.964467.898542.732479.178205.984163.221
General & Administrative Expenses 268.023279.482411.878305.411559.804413.046358.199421.838527.107474.039471.762392.201387.782413.753516.195441.572387.298385.033414.678391.533456.761342.594203.435188.753172.016190.288171.822142.947181.532216.489249.852206.621168.37181.414166.147156.18121.504160.264109.129
Selling & Marketing Expenses 0-2.442-2.392000000000000000000000000000000000000
SG&A 268.023277.04409.486305.411559.804413.046358.199421.838527.107474.039471.762392.201387.782413.753516.195441.572387.298385.033414.678391.533456.761342.594203.435188.753172.016190.288171.822142.947181.532216.489249.852206.621168.37181.414166.147156.18121.504160.264109.129
Other Expenses 2.3020.0471.9040.005-0.349-0.243-4.9310.8860.8450.8980.292000.0360000.2370.147-3.935206.828290.059268.85203.42342.923135.675679.2340.3570.2420.1680.0350.0260.0180.1240.0130.0370.027-18.356-1.117
Operating Expenses 905.34664.141812.062640.3211,623.1341,461.821,495.231,782.1562,777.5281,844.3941,881.0641,687.021,512.5471,540.2521,613.3691,617.3721,328.7481,242.251,880.1291,240.1941,374.7311,438.2411,427.2831,016.801868.6841,162.7661,328.271,141.5891,253.3981,145.634891.79678.073746.362548.378634.045698.912600.682366.248272.35
Operating Income -905.34-666.583-814.454-640.32-1,623.135-1,461.82-1,495.229-1,782.157-2,777.528-1,844.394-1,881.065-1,687.019-1,512.547-1,540.253-1,613.369-1,617.372-1,328.748-1,242.251-1,857.247-1,243.619-1,136.358-1,248.846-1,254.562-863.504-611.538-1,004.315-1,209.054-1,020.218-1,127.345-1,021.764-717.424-604.401-687.62477.22-558.885-10.681-474.127-81.55-163.233
Operating Income Ratio 000000000000000000-81.166363.206-4.767-6.594-7.264-5.633-2.378-6.338-10.142-8.406-8.943-8.249-3.746-8.204-11.7070.123-7.436-0.016-3.746-0.286-1.496
Total Other Income Expenses Net -371.989757.80514.353757.0950.631595.522-3,639.32,993.7591,133.5432.7140.3340.8020.238686.5953,241.595-16.642-371.188-263.523-20.39411.843-176.044514.158-117.687356.17408.18167.904426.892138.031-50.58-75.078364.36119.528-220.544-397.335-4.66-66.16196.62-72.959-11.731
Income Before Tax -1,277.32991.222-800.101116.775-992.511-866.298-5,134.5291,211.602-1,643.985869.469-1,547.104-886.01-1,273.652-853.6571,628.226-1,634.014-1,699.936-1,505.773-1,877.641-1,231.775-1,312.402-734.688-1,372.25-507.334-203.359-836.41-782.163-882.188-1,177.924-1,096.842-353.061-584.874-908.168-320.115-563.545-76.842-377.507-154.509-174.963
Income Before Tax Ratio 000000000000000000-82.058359.747-5.506-3.879-7.945-3.309-0.791-5.279-6.561-7.269-9.345-8.855-1.843-7.939-15.461-0.512-7.498-0.112-2.983-0.543-1.603
Income Tax Expense -113.053236.072-38.821212.301168.853-240.137-1,332.953814.619195.2331,185.24215.26595.4570.3036.408172.4790.3030.3021.294-0.8680.3170.3021.458-1.1340.3510.8791.114-0.8070.7620.770.485-209.543-38.472-40.194-42.713-45.95-46.041-46.58-45.4342.708
Net Income -1,164.276-144.85-761.281-95.527-1,161.363-626.161-3,801.577396.985-1,839.219-315.773-1,562.368-981.467-1,273.955-860.0661,455.748-1,634.317-1,700.239-1,507.067-1,876.773-1,232.092-1,312.704-736.147-1,371.115-507.686-204.237-837.525-781.356-882.949-1,178.695-1,097.327-143.518-546.402-867.974-277.402-517.595-30.8-330.927-109.075-177.671
Net Income Ratio 000000000000000000-82.02359.84-5.507-3.887-7.938-3.312-0.794-5.286-6.554-7.275-9.351-8.859-0.749-7.417-14.777-0.443-6.887-0.045-2.615-0.383-1.628
EPS -17.01-2.12-11.46-1.46-17.89-9.68-61.146.66-32.28-5.98-30.17-18.95-24.6-16.6128.11-31.56-32.83-29.1-36.24-23.79-26.4-14.8-27.57-11.09-4.46-18.3-17.18-19.5-26.03-24.24-3.18-12.24-19.45-6.22-11.61-0.71-7.59-2.67-4.07
EPS Diluted -17.01-2.12-11.46-1.46-17.89-9.68-61.146.66-30.86-5.98-30.17-18.95-24.6-16.6128.11-31.56-32.83-29.1-36.24-23.79-26.4-14.8-27.57-10.21-4.46-18.3-17.07-19.29-26.03-24.24-3.17-12.07-19.45-6.22-11.6-0.69-7.59-2.67-4.07
EBITDA -1,275.126-664.141-812.06295.569-989.741-934.766-5,131.381,218.941-1,636.68876.946-1,539.066-875.503-1,405.796-843.235-1,680.325-1,620.468-1,688.332-1,494.122-1,863.211-1,220.348-1,300.115-715.508-1,362.264-499.643-195.537-828.643-775.062-875.627-1,176.865-1,094.143-349.463-582.614-908.62-312.972-558.968-72.253-373.015-150.041-171.284
EBITDA Ratio 000000000000000000-81.427356.41-5.454-3.778-7.887-3.259-0.76-5.23-6.501-7.215-9.336-8.833-1.825-7.908-15.469-0.5-7.437-0.105-2.947-0.527-1.57